Octanate (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate, is a blood coagulation factor presented as an intravenous solution for intravenous use. It replaces deficient clotting factor in patients with hemophilia A, helping to control and prevent bleeding episodes. GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octanate is a recombinant factor VIII product used in the management of hemophilia A, a disorder of the clotting cascade.

- Hemophilia A (severe): Provides replacement therapy to prevent or control bleeding episodes. - Hemophilia A (moderate): Supports prophylactic treatment to reduce frequency of bleeds. - Hemophilia A (mild) and peri‑operative management: Supplies factor VIII for surgical procedures to maintain hemostasis. - Inhibitor development monitoring: Used in immune tolerance induction protocols to reduce inhibitor formation. - Bypass  ​  ​  ​  ​ ​  ​ ​ ​ ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Octanise     ​  ​  … ​  … … … … ... 

Common   t    g  t  ",